CurrentBlue Cross Blue Shield - Rhode IslandPolicy N/A

Automated Diagnostic Testing Devices — Coverage Criteria

Policy governing coverage, coding, and payment for fully or partially automated diagnostic testing devices and their use by providers contracting with Blue Cross & Blue Shield of Rhode Island (BCBSRI). Applies to providers submitting claims for such testing to BCBSRI.

Policy Summary

PayerBlue Cross Blue Shield - Rhode Island

PolicyAutomated Diagnostic Testing Devices — Coverage Criteria

Policy CodePolicy N/A

Change TypeNo material changes

Effective DateN/A

Next Review DateN/A

Key ActionFollow code-specific prior authorization processes and request BCBSRI policy rulings when reporting unlisted procedures.

SourceLink

POLICY UPDATE CHANGES

No material clinical or coverage changes in this revision.

0.01presumed separate-service allowance unless otherwise specified

Code-specificPrior authorization requirement

Not applicableMedical criteria

Device-specificCoding approach

Coverage Criteria

Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

Covered with conditions

Covered when ALL of the following are met

General coverage conditions: 1) The testing is medically necessary for the member; 2) The service is a covered benefit under the member's contract (refer to the Evidence of Coverage or Subscriber Agreement); 3) The performing and reporting provider is eligible to be contracted/participating with BCBSRI as determined by BCBSRI; 4) The reporting provider is qualified to perform the test or use trained technical personnel, personally interpret results, and perform necessary quality control functions to validate test quality; 5) Coding used accurately reflects the service and is supported by written guidance from BCBSRI or AMA-CPT; if existing CPT/HCPCS codes do not accurately describe the automated device testing, providers must report an unlisted procedure code and request BCBSRI adjudication; 6) FDA approval alone is insufficient to establish coverage.

Reflects policy requirements on medical necessity, provider qualifications, coding, and adjudication.

Covered Indications

Automated device testing for diagnostic or screening purposes where medically necessary and clinically appropriate for the specific indication.

Covered when ALL of the following are met

Automated device testing — diagnostic or screening purposes: 1) The automated or semi-automated device testing is medically necessary and clinically appropriate for the specific diagnostic or screening indication; 2) Coverage is subject to the member's contract terms (see Evidence of Coverage or Subscriber Agreement); 3) The reporting provider meets qualifications and competency expectations to interpret results and perform quality control; 4) The reporting and coding of the device test must be accurate and supported by BCBSRI or AMA-CPT written guidance — manufacturer coding guidance alone is not acceptable; 5) When existing CPT/HCPCS codes do not appropriately describe the automated test, use an unlisted procedure code and obtain BCBSRI adjudication; 6) BCBSRI may determine that certain device-performed tests are not medically necessary even if they can be reported with an otherwise covered CPT/HCPCS code.

Applies generically to automated device testing for diagnostic or screening purposes; coverage varies by contract.

Coding and Billing

Unlisted / device-specific codingCPT

unlisted procedure

Use of an unlisted procedure code may be required when existing CPT/HCPCS codes do not accurately describe automated device testing; such reporting requires BCBSRI adjudication.

Presumed allowance for separately reported automated test

Presumed separate-service allowance$0.01 when the service is reported separately unless BCBSRI provides otherwise in writing

ApplicabilityApplies when automated-device testing is reported separately from other services and BCBSRI has not provided a different written allowance

ConditionPayment at $0.01 may be used notwithstanding that the test is reported with a medically necessary CPT/HCPCS code if BCBSRI has not determined otherwise

Provider Actions and Requirements

Prior Authorization

Prior Authorization Required

Prior Authorization is required and is code-specific. Providers must obtain prior authorization for services reported with specific CPT/HCPCS or unlisted procedure codes when BCBSRI requires it; authorization applies to the exact code(s) submitted.

Code-specific prior authorization applies to automated-device testing and to unlisted procedure codes when BCBSRI has established coverage rules.

Documentation Required

Documentation and Rulings Required for Unlisted Procedures

When reporting an unlisted procedure code for testing performed with an automated or new technology device, participating providers must request a policy ruling from BCBSRI before performing the service. The provider must submit complete documentation to support medical necessity and the clinical and technical details of the service so BCBSRI can adjudicate coverage and payment.

Request a written policy ruling from BCBSRI for any unlisted procedure code prior to performing the service.
Provide full clinical documentation, device description, methodology, intended clinical use, and evidence supporting equivalence or superiority to traditional testing.
Do not rely on manufacturer coding guidance alone; BCBSRI requires independent supporting documentation.

Note

Confirmatory/Testing Context

BCBSRI may require that results from automated or semi-automated devices be considered in the context of traditional/confirmatory testing. Providers should be prepared to document confirmatory testing when requested and to demonstrate that the automated device’s performance, interpretation, and quality control meet clinical standards.

Be ready to provide confirmatory test results or rationale for clinical interpretation when BCBSRI requests it.
Document device sensitivity/specificity, quality control procedures, and how results were interpreted by the reporting provider.

Denial Risk

Denial and Sanction Risks for Incorrect Coding

Incorrect coding, misrepresentation of the service, or reliance on inappropriate codes may lead to denials, recoupment, termination of participation, or allegations of fraud. Providers are responsible for correct code selection; AMA‑CPT or written BCBSRI guidance are acceptable supports for coding assertions.

Do not report automated-device testing with existing CPT/HCPCS codes unless supported by AMA‑CPT guidance or written BCBSRI direction.
If BCBSRI has not published guidance, assume an unlisted procedure code may be appropriate and request a policy ruling.
Maintain documentation of any written BCBSRI guidance or AMA‑CPT coding that supports the code used.

Ordering Requirements

Note

Provider eligibility and qualification required to order/report

Services must be performed and reported by providers who are eligible to contract/participate with BCBSRI and who are qualified to perform the test, use trained technical personnel, and personally interpret and validate test quality.

Reporting providers must be able to perform necessary quality control functions and understand device performance, appropriate clinical uses, and result interpretation.
BCBSRI reserves the right to determine requisite qualifications for reporting providers.

Definitions

Automated device testing — definition

DefinitionDiagnostic or screening tests performed wholly or partly by automated or semi-automated devices that may generate results and/or provisional reports with less hands-on technician work or manual interpretation compared with traditional laboratory tests

Typical characteristicsMay produce full data for interpretation, a provisional report, or only a pass/fail result; may be used in nontraditional settings for screening (e.g., workplace or school)

Clinical considerationsDevices can differ in sensitivity, specificity, and intended clinical use from traditional methods and may require confirmatory testing or different interpretation approaches

Coding noteAMA‑CPT includes Category I/III codes and may direct use of an unlisted procedure code when existing codes do not accurately describe automated services

Background

Automated and semi‑automated devices may produce a range of outputs, from numeric results to provisional reports or simple pass/fail indications. These outputs and the devices' intended clinical uses can differ from traditional laboratory methods in sensitivity, specificity, and interpretation requirements. Because device‑generated data or manufacturer coding guidance alone are not accepted as sufficient justification, reporting providers must be qualified to perform the test, use trained technical personnel, carry out required quality control functions, and personally interpret results and device performance. FDA approval alone is not sufficient to establish coverage.

OpenPayer